Pharmaceutical companies are investing in the development of personalized vaccines against cancer, offering promising results in reducing the risk of relapse, but questions remain regarding their overall effectiveness and financial accessibility. (translated)
Moderna and Merck laboratories announced promising results of a personalized vaccine against relapses of skin cancer, offering new hope to patients with melanoma, according to oncologist Suzette Delaloge, who emphasizes the importance of this advance and the anticipation of detailed data to come. (translated)
Merck and Moderna announced positive results for a messenger RNA therapeutic vaccine against advanced melanoma, showing a significant improvement in recurrence-free survival in combination with the immunotherapy Keytruda, marking an important advance in personalized treatments for this deadly skin cancer. (translated)
The laboratories Moderna and Merck announced promising results for their therapeutic vaccine against melanoma, which, in combination with the immunotherapy Keytruda, showed a significant improvement in relapse-free survival in patients with advanced skin cancer. (translated)
Belgian researchers from the Flanders Institute of Biotechnology and KU Leuven have discovered how liver cancer cells evade the immune system, thereby paving the way for new treatment possibilities by restoring the anti-cancer activity of immune cells and slowing the growth of metastases. (translated)
AstraZeneca envisions a $400 billion merger with Bristol-Myers Squibb, benefiting from the complementarity of their portfolios focused respectively on cancer treatment and rare diseases, and on immunotherapy. (translated)
@MiesBee Nee Mies! Niet tof dit, het kan gewoon hè, ik heb ook uitgezaaide nierkanker en voel me beter dan voor mijn diagnose. Als je het geluk hebt dat de , bij mij, immuuntherapie aanslaat kan je er nog een paar jaar bijkrijgen, maar het is ook de hel iedere drie maanden #Kanker #Immunotherapie #Gezondheid
Deux études présentées au Congrès annuel du cancer de Chicago révèlent une nouvelle génération d'immunothérapie et une thérapie ciblée qui montrent des résultats prometteurs contre le cancer du poumon non à petites cellules, soulignant l'importance d'un dépistage précoce des patients. #CancerDuPoumon #Immunothérapie #ThérapieCiblée
Le professeur Didier Ebo, allergologue à l'UAntwerpen, démystifie 15 mythes sur l'allergie au pollen, en soulignant que près d'un Belge sur trois en souffre, que son incidence augmente en raison de l'hygiène et du changement climatique, et que des traitements comme l'immunothérapie peuvent aider à atténuer ou à éliminer les symptômes. #allergie #pollen #santé
